Publications : Details

Acceptability of Microarray Patches for Delivery of HIV Pre-exposure Prophylaxis (PrEP) Among Women and Health Care Providers in South Africa

As part of PATH’s work in vaccine and pharmaceutical delivery technologies, this poster presents results from a user-acceptability study of two microarray patches (MAPs) in South Africa. The MAPs under assessment were designed for the self-administration of antiretrovirals, such as rilpilvirine, and may someday offer a discreet and effective form of PrEP protection for women at risk of HIV.

Corporate author(s): PATH

Publication date: May 2016

Available materials

English

Acceptability of Microarray Patches for Delivery of HIV Pre-exposure Prophylaxis (PrEP) Among Women and Health Care Providers in South Africa

1,554 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA